Abiopharma

News list

Young David 🟢 acquired 1.7K shares of Processa Pharmaceuticals, Inc. (PCSA) at $2.69 Transaction Date: Apr 30, 2026 | Filing ID: 001010

Full text

News bot May 1, 2026, 8:40 p.m.
🔍 Young David (Executive)

Company: Processa Pharmaceuticals, Inc. (PCSA)

Report Date: 2026-04-30
Transaction Summary:
- Total transactions: 4
- Derivative instruments: 0
- Holdings reported: 3
- Total shares acquired: 1,706
- Total shares held: 2,416
Detailed Transactions and Holdings:
- Acquired 1,706 shares of Common Stock at $2.69 per share (Direct)
  Date: 2026-04-30 | Code: P | equity_swap_involved: false | shares_owned_after: 13,813.00 | transaction_form_type: 4
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-30 | Code: H | nature_of_ownership: By Young-Plaisance Revocable Trust | shares_owned_after: 1,242.00
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-30 | Code: H | nature_of_ownership: By Family Entities | shares_owned_after: 432.00
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-30 | Code: H | nature_of_ownership: By CorLyst, LLC | shares_owned_after: 742.00